NASDAQ: FLNA
Filana Therapeutics Inc Stock Ownership - Who owns Filana Therapeutics?

Insider buying vs selling

Have Filana Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard BarryCEO;Pres2026-09-30100,000$0.92
$92.00kBuy
Richard BarryCEO;Pres2026-09-29206,813$0.90
$186.13kBuy
Richard BarryCEO;Pres2026-09-2893,091$0.84
$78.20kBuy
Robert Eugene Anderson Jr.Director2025-11-248,600$2.90
$24.94kBuy
Richard BarryPresident CEO2025-11-20150,000$2.76
$414.00kBuy
Richard BarryPresident CEO2025-11-1973,385$2.75
$201.81kBuy

1 of 1

FLNA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FLNA insiders and whales buy or sell their stock.

FLNA Shareholders

What type of owners hold Filana Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eastbourne Capital Management LLC29.25%14,131,378$9.20MInsider
Remi Barbier18.27%8,827,362$5.75MInsider
Sabretooth Master Fund LP8.82%4,263,076$2.78MInsider
Black Bear Offshore Master Fund LP8.67%4,186,238$2.73MInsider
Richard Barry4.71%2,276,024$1.48MInsider
Armistice Capital LLC3.42%1,651,340$1.08MInsider
Sanford Robertson2.35%1,135,851$739.44kInsider
Peter S. Roddy0.25%121,479$79.08kInsider
Donnell Michael J. O.0.22%105,697$68.81kInsider
Nadav Friedmann0.17%80,053$52.11kInsider

1 of 3

FLNA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FLNA0.03%76.45%Net BuyingNet Buying
ESLA0.01%68.68%Net BuyingNet Buying
AARD0.04%46.39%Net SellingNet Selling
IRLA0.00%100.00%Net Selling
MGX0.02%34.76%Net BuyingNet Buying

Filana Therapeutics Stock Ownership FAQ

Who owns Filana Therapeutics?

Filana Therapeutics (NASDAQ: FLNA) is owned by 0.03% institutional shareholders, 76.45% Filana Therapeutics insiders, and 23.53% retail investors. Eastbourne Capital Management LLC is the largest individual Filana Therapeutics shareholder, owning 14.13M shares representing 29.25% of the company. Eastbourne Capital Management LLC's Filana Therapeutics shares are currently valued at $9.30M.

If you're new to stock investing, here's how to buy Filana Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.